Papillary thyroid cancer medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
Patients with papillary thyroid cancer are treated with radioactive iodine therapy, immunotherapy, hormone therapy and targeted medical therapy. | Patients with papillary thyroid cancer are treated with radioactive iodine therapy, immunotherapy, hormone therapy and targeted medical therapy. | ||
==Medical Therapy== | ==Medical Therapy== | ||
==Radiation Therapy== | ===Radiation Therapy=== | ||
==Immunotherapy== | ===Immunotherapy=== | ||
==Precision Medicine and Targetted Therapy== | ===Precision Medicine and Targetted Therapy=== | ||
==Hormone Therapy== | ===Hormone Therapy=== | ||
* Levothyroxine in a dosage of 2.5-3.5 mcg/kg/day is recommended for patients post thyroidectomy. | * Levothyroxine in a dosage of 2.5-3.5 mcg/kg/day is recommended for patients post thyroidectomy. | ||
==References== | ==References== | ||
Revision as of 21:40, 5 November 2015
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer medical therapy |
|
Risk calculators and risk factors for Papillary thyroid cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Patients with papillary thyroid cancer are treated with radioactive iodine therapy, immunotherapy, hormone therapy and targeted medical therapy.
Medical Therapy
Radiation Therapy
Immunotherapy
Precision Medicine and Targetted Therapy
Hormone Therapy
- Levothyroxine in a dosage of 2.5-3.5 mcg/kg/day is recommended for patients post thyroidectomy.